News

Balt receives IDE approval from the FDA to begin the STEM Trial

Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma.

Discover the Press Release

Other News

News
Sep 18, 2024

Official visit to our office in Montmorency, France

Read More
Official visit to our office in Montmorency, France
News
Jun 13, 2024

Balt in the news

Read More
Balt
News
May 31, 2024

Mayor of Montmorency visits our site

Read More
Mayor of Montmorency visits our site
News
May 30, 2024

French Government awards €4.2millon for an innovative treatment of hemorrhagic stroke, to be developed by Balt

Read More
French Government awards €4.2millon for an innovative treatment of hemorrhagic stroke, to be developed by Balt
News
Apr 17, 2024

Official visit at our Irvine (California) site

Read More
Official visit at our Irvine (California) site
News
Feb 09, 2024

STEM Clinical Trial

Read More
STEM Clinical Trial
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.

EN